Skip to search formSkip to main contentSkip to account menu

Angiotensin 2 Receptor Blocker [EPC]

Known as: Angiotensin 2 Receptor Blocker, Angiotensin II Receptor Blocker 
National Institutes of Health

Related topics

Related topics

3 relations
Angiotensin 2 Receptor Antagonists [MoA]Angiotensin 2 Type 1 Receptor Antagonists [MoA]Angiotensin II receptor antagonist

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Telmisartan induces browning of fully differentiated white adipocytes via M2 macrophage polarization
Telmisartan is a well-known anti-hypertensive drug acting as an angiotensin 2 receptor blocker (ARB), but it also possesses… 
2015
2015
911 A Novel Use of Angiotensin II Receptor Blocker (ARB) Losartan to Inhibit AOM Induced Tumorigenesis and Neoangiogenesis in Experimental Colon Cancer
2012
2012
Telmisartan reduces triglyceride levels over other angiotensin II receptor blockers: a meta-analysis of randomized head-to-head trials.
2011
2011
Effects of an Angiotensin 2 Receptor Blocker plus Diuretic Combination Drug in Chronic Heart Failure Complicated by Hypertension
The effects of 24 weeks' treatment with an angiotensin 2 receptor blocker (ARB)/diuretic combination drug were investigated in an… 
Highly Cited
2008
Highly Cited
2008
Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes
We investigated whether aliskiren, a direct renin inhibitor, improves NO bioavailability and protects against spontaneous… 
Highly Cited
2008
Highly Cited
2008
Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin…
Although dual blockade of the renin-angiotensin-aldosterone system (RAAS) with the combination of an angiotensin-converting… 
2005
2005
Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients
The purpose of this study is to compare the long-term effects of an angiotensin II receptor blocker (ARB) and a long-acting… 
Highly Cited
2005
Highly Cited
2005
Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.
OBJECTIVE The objective of this study was to evaluate the safety and short-term effect of adding spironolactone to conventional… 
Highly Cited
2004
Highly Cited
2004
Evidence of tubular hypoxia in the early phase in the remnant kidney model.
The remnant kidney model is a mainstay in the study of progressive renal disease. The earliest changes in this model result from… 
Highly Cited
2003
Highly Cited
2003
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.
OBJECTIVE We evaluated the renoprotective effects as reflected by short-term changes in albuminuria of dual blockade of the renin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)